A phase II study of ARA 290 as therapeutic strategy in rheumatoid arthritis - ARARA

eids Universitair Medisch Centrum0 个研究点目标入组 14 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•Patients with active rheumatoid arthritis, classified by the ARA criteria (1987) aged 18+

•Current treatment with biological agent or treatment with biological in the 2 months before inculsion.
•Clinically relevant abnormal laboratory results, ECG, vital signs, or physical findings other than conditions related to rheumatoid arthritis (as judged by the investigator)
•Pregnancy or wish to become pregnant during the study, or childbearing potential without adequate contraception
•Participation in an investigational drug trial, current or in the 3 months prior to administration of the initial dose of study drug or more than 4 times per year
•Use of erythropoietin
•Inability to follow the protocol and to comply with the follow up requirements
•Clinically relevant abnormal history of physical and mental health other than conditions related to rheumatoid arthritis, as determined by medical history taking (as judged by the investigator) or any other condition that in the opinion of the investigator would complicate or compromise the well being of the subject.
•Current or previous TBC infection

发起方